Roupen Odabashian: Efficiency and patient privacy drive healthcare adoption
Roupen Odabashian, Internal Medicine Physician and Hematology/Oncology Fellow at Karmanos Cancer Institute, posted the following on LinkedIn:
“3D-printed casts haven’t gained traction in healthcare because they are slower to produce compared to traditional casts made by orthopedic surgeons.
While they are visually appealing and potentially cheaper, adoption remains low among orthopedic surgeons and ER docs.
In healthcare, what drives adoption is efficiency and patient privacy, not just innovation.”
Dr. Roupen Odabashian is an accomplished Internal Medicine Physician and Hematology/Oncology Fellow with a profound commitment to advancing healthcare through clinical practice, research, and technology. Currently based at the prestigious Karmanos Cancer Institute, Dr. Odabashian is actively involved in pioneering cancer treatments and conducting clinical research.
In addition to his clinical work he hosts podcast at OncoDaily, engaging with leading experts in oncology to share valuable insights with the medical community. Dr. Odabashian also contributes his expertise as an advisor at Spiraldot Health and Mesh AI, supporting innovative ventures in healthcare technology and collaborative scheduling to combat clinician burnout. With his diverse roles and unwavering dedication, Dr. Odabashian exemplifies a commitment to driving positive change in healthcare.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023